A Bayesian model for joint analysis of multivariate repeated measures and time to event data in crossover trials

Statistical Methods in Medical Research

Volumn 25, Issue 5, 2016, Pages 2180-2192

  Liu, Fang ^a   Li, Qing ^b  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Bayesian joint modeling; crossover trials; fixed boundaries inflation; multi level random effects; non linear mixed model; zero one inflated beta regression

Indexed keywords

HUMAN; JOINT; MAXIMUM LIKELIHOOD METHOD; STATISTICAL MODEL; VISUAL ANALOG SCALE; ANTAGONISTS AND INHIBITORS; BAYES THEOREM; CLINICAL TRIAL (TOPIC); CROSSOVER PROCEDURE; HEAT; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MARKOV CHAIN; MONTE CARLO METHOD; PROCEDURES;

TRPV1 PROTEIN, HUMAN; VANILLOID RECEPTOR;

BAYES THEOREM; CLINICAL TRIALS AS TOPIC; CROSS-OVER STUDIES; HOT TEMPERATURE; HUMANS; KAPLAN-MEIER ESTIMATE; LIKELIHOOD FUNCTIONS; LONGITUDINAL STUDIES; MARKOV CHAINS; MONTE CARLO METHOD; TRPV CATION CHANNELS;

EID: 84989819163     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280213519594     Document Type: Article

References (22)

1. Hogan JW, Laird NM,. Model-based approaches to analysing incomplete longitudinal and failure time data. Stat Med 1997; 16: 259-272.
2. Henderson R, Diggle P, Dobson A,. Joint modeling of longitudinal measurements and event time data. Biostatistics 2000; 1: 465-480.
3. Chi Y-Y, Ibrahim JG,. Joint models for multivariate longitudinal and multivariate survival data. Biometrics 2006; 62: 432-445.
4. Lin H, McCulloch CE, Mayne ST,. Maximum likelihood estimation in the joint analysis of time-to-event and multiple longitudinal variables. Stat Med 2002; 21: 2369-2382.
5. Rizopoulos D, Verbeke G, Lesaffre E, et al. A two-part joint model for the analysis of survival and longitudinal binary data with excess zeros. Biometrics 2008; 64: 611-619.
6. Elashoff RM, Li G, Li N,. A joint model for longitudinal measurements and survival data in the presence of multiple failure types. Biometrics 2008; 64: 762-771.
7. Chi Y-Y, Ibrahim JG,. Bayesian approaches to joint longitudinal and survival models accommodating both zero and nonzero cure fractions. Stat Sin 2007; 17: 445-462.
8. Yu M, Law NJ, Taylor JMG, et al. Joint longitudinal-survival cure models and their application to prostate cancer. Stat Sin 1996; 14: 835-862.
9. Tseng Y-K, Hseih F, Wang J-L,. Joint modelling of accelerated failure time and longitudinal data. Biometrika 2005; 92: 587-603.
10. Brown ER, Ibrahim JG,. A Bayesian semiparametric joint hierarchical model for longitudinal and survival data. Biometrics 2003; 59: 221-228.
11. Wang Y, Taylor JMG,. Jointly modeling longitudinal and event time data with application to acquired immunodeficiency syndrome. J Am Stat Assoc 2001; 96: 895-905.
12. Andersen PK, Gill RD,. Cox's regression model for counting processes: a large sample study. Ann Stat 1982; 10: 1100-1120.
13. Clayton D,. Bayesian analysis of frailty models, technical report, Cambridge: Medical Research Council Biostatistics Unit, 1994.
14. Bae K, Mallick BK,. Gene selection using a two-level hierarchical Bayesian model. Bioinformatics 2004; 18: 3423-3430.
15. Kalbfleisch JD,. Non-parametric Bayesian analysis of survival time data. J R Statist Soc B 1978; 40: 214-221.
16. Neito-Barajas LE, Walker SG,. Markov beta and gamma processes for modelling hazard rates. Scand J Stat 2002; 29: 413-414.
17. Gelman A,. Prior distributions for variance parameters in hierarchical models. Bayesian Anal 2006; 1: 515-533.
18. Plummer M. http://mcmc-jags.sourceforge.net/.
19. Plummer M and Stukalov A. http://cran.r-project.org/web/packages/rjags/rjags.pdf.
20. Gelfand AE, Sahu SK, Carlin BP,. Efficient parametrisations for normal linear mixed models. Biometrika 1995; 82: 479-488.
21. Gelman A, Rubin DB,. Inference from iterative simulation using multiple sequences. Stat Sci 1992; 7: 457-511.
22. Brooks SP, Gelman A,. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 1998; 7: 434-455.